Results 101 to 110 of about 1,208 (179)

Cell-Free DNA Fragments as Biomarkers in Radiooncology and Gynecology [PDF]

open access: yes
Liquid biopsy of cell-free DNA (cfDNA) is a non-invasive diagnostic method that provides valuable biological insights into various diseases by analyzing DNA fragments released into the bloodstream.
Ivankovic, Ivna
core   +2 more sources

Systematic biases in reference-based plasma cell-free DNA fragmentomic profiling

open access: yes
Plasma cell-free DNA (cfDNA) fragmentation patterns are emerging directions in cancer liquid biopsy with high translational significance. Conventionally, the cfDNA sequencing reads are aligned to a reference genome to extract their fragmentomic features.
Pan, Yuqi   +8 more
core   +1 more source

Piecing together pregnancy’s early warning system

open access: yes
cfDNA fragmentomics of routine prenatal screening data identifies adverse pregnancy outcomes in immune-mediated disease (Stanley et al. , this issue).
Nima Aghaeepour, Mohammad Amin Sadeghi
core   +1 more source

DeepFRAG: a method for cancer detection based on DNA fragmentomics and deep learning

open access: yesBioinformatics Advances
Abstract Motivation Cancer screening using liquid biopsy technology has become standard in modern clinical and preventive oncology. This method analyzes cell-free DNA (cfDNA) circulating in a patient’s bloodstream.
Andrey Koch, Eldar Giladi
openaire   +3 more sources

Fragmentation signatures in cancer patients resemble those of patients with vascular or autoimmune diseases

open access: yes
Multiple case-controlled studies have shown that analyzing fragmentation patterns in plasma cell-free DNA (cfDNA) can distinguish individuals with cancer from healthy controls.
Kinzler, KW   +31 more
core   +1 more source

Cancer‐Like Fragmentomic Characteristics of Somatic Variants in Cell‐Free DNA

open access: yesAdvanced Science
ABSTRACT Cell‐free DNA (cfDNA) in plasma consists of short DNA fragments resulting from a non‐random fragmentation process, with distinct fragmentomic characteristics that are related with their cellular origins. Here, we report that somatic variant signatures in cfDNA markedly differ between non‐cancerous controls and cancer patients,
Zhenyu Zhang   +12 more
openaire   +2 more sources

Chasing the code : Advancing Precision Diagnostics through Next Generation Sequencing

open access: yes
Next generation sequencing (NGS) has revolutionized precision diagnostics by enabling high-throughput analysis of nucleic acids. This thesis combines technical validations with innovative applications of NGS across five studies.
Adolfsson, Emma
core   +2 more sources

Integration of Cell-Free DNA End Motifs and Fragment Lengths Can Identify Active Genes in Liquid Biopsies

open access: yes
Multiple studies have shown that cell-free DNA (cfDNA) from cancer patients differ in both fragment length and fragment end motif (FEM) from healthy individuals, yet there is a lack of understanding of how the two factors combined are associated with ...
Anders Lade Nielsen   +4 more
core   +1 more source

Cell-free DNA fragmentome analysis informs pregnancy outcome in patients with immune-mediated disease

open access: yes
Pregnancy complications contribute substantially to maternal and fetal morbidity and mortality. If complications are suspected early in pregnancy, individuals could be triaged to escalate care and ideally reduce adverse outcomes.
Bernard Thienpont   +12 more
core   +1 more source

Home - About - Disclaimer - Privacy